GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

“The real stroke of brilliance is the notion that you make the cell younger, and then it would be more resilient to injury,” ...

Drugs like Ozempic and Wegovy could raise the risk of a rare form of vision loss, but we are still trying to unpick why ...

But, after getting a CT-scan and seeing a neuro-ophthalmologist, it was revealed he had non-arteritic anterior ischemic optic neuropathy (NAION), a condition in which the loss of blood flow to the ...

Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...

Patients using popular weight loss medications, such as Ozempic and Wegovy, are being urged to undergo eye examinations due ...

Non-arteritic anterior ischemic optic neuropathy (NAION) - also known as a "eye stroke" - typically causes sudden vision loss in one eye. It occurs from a lack of sufficient blood flow to the ...

Patients on semaglutide (Ozempic, Wegovy) had a 32% increased relative risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) compared to people not taking the drug ...

Nonarteritic anterior ischemic optic neuropathy—known as NAION—can cause sudden blindness when blood flow to the optic nerve is blocked. It’s not clear what causes the condition, although ...

Semaglutide is associated with a slightly increased risk of a potentially blinding eye condition People taking semaglutide had a 32% increased relative risk of NAION NAION causes sudden vision ...